TScan Therapeutics, Inc.

Historical 13F Holders

Symbol
TCRX
CUSIP
89854M101
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 89854M101 since 12/18/2024, largest first.

Filer % of Class Filed
Lynx1 Capital Management LP 13G/A
13.1% 8/14/2026
Event 6/30/2026
Biotechnology Value Fund L P 13G/A
10.0% 8/14/2026
Event 6/30/2026
Adage Capital Partners GP, L.L.C. 13G/A
7.1% 2/12/2025
Event 12/31/2024
K2 HealthVentures Equity Trust LLC 13G/A
6.9% 2/14/2025
Event 12/31/2024
Readout Capital, LP 13G
5.4% 9/25/2026
Event 9/21/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Adage Capital Management, L.P. 13G/A
2.5% 8/12/2025
Event 6/30/2025
BlackRock, Inc. 13G/A 1.8% 7/16/2025
Event 6/30/2025
EcoR1 Capital, LLC 13G/A
1.3% 5/15/2025
Event 3/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 52 32.7 M $10.3M
2026 Q2 60 35.8 M $35.1M
2026 Q1 60 32.5 M $32.8M
2025 Q4 61 30.7 M $30.7M
2025 Q3 73 34.6 M $62.9M
2025 Q2 82 35.7 M $51.8M
2025 Q1 93 40.1 M $55.4M
2024 Q4 91 41.5 M $126M
2024 Q3 90 41.8 M $208M
2024 Q2 82 41.5 M $243M
2024 Q1 67 34.3 M $272M
2023 Q4 55 31.9 M $186M
2023 Q3 33 28.6 M $73.2M
2023 Q2 29 28.0 M $69.9M
2023 Q1 29 9.67 M $20.3M
2022 Q4 29 9.52 M $14.8M
2022 Q3 27 9.51 M $29.0M
2022 Q2 25 9.68 M $30.4M
2022 Q1 26 9.41 M $26.3M
2021 Q4 30 9.86 M $44.4M
2021 Q3 28 10.1 M $83.5M